List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 174 studies with search of: "Amlodipine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension
Condition: Hypertension
Interventions: Drug: Aliskiren;   Drug: Aliskiren;   Drug: Amlodipine;   Drug: Amlodipine;   Drug: Aliskiren/amlodipine;   Drug: Aliskiren/amlodipine;   Drug: Aliskiren/amlodipine;   Drug: Aliskiren/amlodipine;   Drug: Placebo
2 Recruiting Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone
Condition: Hypertension
Interventions: Drug: Amlodipine 10 mg;   Drug: Aliskiren/Amlodipine 150/10 mg;   Drug: Aliskiren/Amlodipine 300/10 mg
3 Recruiting Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for Hypertension
Condition: Hypertension
Interventions: Drug: Amlodipine and Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ;   Drug: Aliskiren and Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ;   Drug: Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ
4 Recruiting Efficacy and Safety of Aliskiren +/- Ramipril When Added to Amlodipine in Hypertensive Patients With Metabolic Syndrome
Condition: Hypertension With Metabolic Syndrome
Interventions: Drug: ramipril/amlodipine (10/10 mg);   Drug: aliskiren/amlodipine (300/10 mg);   Drug: aliskiren/ramipril/amlodipine (300/10/10mg)
5 Completed A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting Conditions
Condition: Healthy
Interventions: Drug: AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose;   Drug: Norvasc® 10 mg Tablets
6 Completed A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed Conditions
Condition: Healthy
Interventions: Drug: AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose;   Drug: NorvasC® 10 mg Tablets
7 Recruiting Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-Severe Hypertension
Condition: Moderate-Severe Hypertension
Interventions: Drug: Aliskiren 150/Amlodipine 5 mg, 300/10 mg;   Drug: Aliskiren 150/Hydrochlorothiazide 12.5 mg, 300/25 mg;   Drug: Amlodipine 150/Hydrochlorothiazide 12.5 mg, 10/25 mg;   Drug: Aliskiren 150/Amlodipine 5/Hydrochlorothiazide 12.5 mg, 300/10/25 mg
8 Recruiting Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 Hypertension
Condition: Hypertension
Interventions: Drug: Aliskiren/Amlodipine;   Drug: Amlodipine
9 Active, not recruiting A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
Conditions: Hypertension;   Obesity
Interventions: Drug: Telmisartan plus Metformin;   Drug: Telmisartan;   Drug: Candesartan;   Drug: Candesartan plus Metformin;   Drug: Amlodipine;   Drug: Amlodipine plus Metformin
10 Completed Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension
Condition: Hypertension
Interventions: Drug: Valsartan plus amlodipine;   Drug: Amlodipine
11 Recruiting Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension
Condition: Moderate to Severe Hypertension
Interventions: Drug: Aliskiren/Amlodipine;   Drug: Amlodipine
12 Completed 8-Week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe Hypertension
Condition: Hypertension
Interventions: Drug: Valsartan + amlodipine;   Drug: Valsartan + HCTZ;   Drug: Amlodipine + HCTZ;   Drug: Valsartan + amlodipine + HCTZ
13 Recruiting A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives
Conditions: Obesity;   Hypertension
Interventions: Drug: eplerenone, amlodipine;   Drug: eplerenone;   Drug: eplerenone;   Drug: amlodipine
14 Completed Safety and Efficacy of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: Valsartan/Amlodipine;   Drug: Amlodipine
15 Completed Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
Condition: Hypertension
Interventions: Drug: Valsartan/hydrochlorothiazide (HCTZ);   Drug: Valsartan/amlodipine;   Drug: Amlodipine/hydrochlorothiazide(HCTZ);   Drug: Valsartan/amlodipine/hydrochlorothiazide(HCTZ)
16 Completed Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
Condition: Hypertension
Interventions: Drug: fixed dose combination of telmisartan+amlodipine;   Drug: amlodipine
17 Completed Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
Condition: Hypertension
Interventions: Drug: fixed dose combination of telmisartan+amlodipine;   Drug: amlodipine
18 Recruiting Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension
Condition: Hypertension
Interventions: Drug: Amlodipine/Valsartan;   Drug: Amlodipine
19 Completed
Has Results 		A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin
Conditions: Hypertension;   Hypercholesterolemia
Interventions: Drug: Amlodipine 2.5mg/Atorvastatin 5mg;   Drug: Amlodipine 2.5mg/Atorvastatin 10mg;   Drug: Amlodipine 5mg/Atorvastatin 5mg;   Drug: Amlodipine 5mg/Atorvastatin 10mg
20 Active, not recruiting Efficacy and Safety of TAK-491 Co-Administered With Amlodipine in Subjects With Essential Hypertension
Condition: Essential Hypertension
Interventions: Drug: TAK-491;   Drug: TAK-491;   Drug: Amlodipine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services